Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-08

Clinical Trial Update: Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two doses of QVAR with placebo in moderate asthma patients (adolescents and adults) on stable inhaled corticosteroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QVAR (beclomethasone dipropionate inhalation aerosol)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED